Antitumor and antimetastatic effects of dietary sulforaphane in a triple-negative breast cancer models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Antitumor and antimetastatic effects of dietary sulforaphane in a triple-negative breast cancer models ; volume:14 ; number:1 ; day:11 ; month:7 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (11.7.2024), 1-11, 12.2024
- Urheber
-
Pogorzelska, A.
Świtalska, M.
Wietrzyk, J.
Mazur, M.
Milczarek, M.
Medyńska, K.
Wiktorska, K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-65455-w
- URN
-
urn:nbn:de:101:1-2409282113467.652999788930
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pogorzelska, A.
- Świtalska, M.
- Wietrzyk, J.
- Mazur, M.
- Milczarek, M.
- Medyńska, K.
- Wiktorska, K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
A recent overview on sulforaphane as a dietary epigenetic modulator
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
A recent overview on sulforaphane as a dietary epigenetic modulator
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
A recent overview on sulforaphane as a dietary epigenetic modulator
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer